Literature DB >> 346215

High-dose methotrexate in osteogenic sarcoma: a 5-year experience.

N Jaffe, E Frei, H Watts, D Traggis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 346215

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  17 in total

1.  Adenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp.

Authors:  Hui Zhao; Changliang Peng; Guorui Ruan; Junlin Zhou; Yihan Li; Yong Hai
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Current impact of adjuvant chemotherapy in resectable cancer.

Authors:  A Rossi; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 3.  Surgical pathology of bone sarcomas.

Authors:  A G Huvos
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

4.  Ferrokinetics after high-dose methotrexate therapy.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Klin Wochenschr       Date:  1981-10-01

5.  A microbiological assay for the measurement of methotrexate in biological fluids.

Authors:  G C Icke; R E Davis; J Thom
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

6.  The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation.

Authors:  V P Chuang; S Wallace; R S Benjamin; N Jaffe; A Ayala; J Murray; J Zornoza; Y Patt; G Mavligit; C Charnsangavej; C S Soo
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

7.  Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth.

Authors:  J H Mulder; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.

Authors:  Hui Zhao; Wei Guo; Changliang Peng; Tao Ji; Xinchang Lu
Journal:  Mol Biol Rep       Date:  2009-08-22       Impact factor: 2.316

Review 9.  Adjuvant chemotherapy of cancer. A review of its current status.

Authors:  S K Carter
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

10.  Reduction in the toxicity of aminopterin--monoclonal-antibody conjugates by leucovorin.

Authors:  A J Rowland; G A Pietersz
Journal:  Cancer Immunol Immunother       Date:  1994-08       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.